Related Experiment Video
Updated: May 20, 2026

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
Published on: January 17, 2025
Biliary cystadenomas: a case for complete resection.
Sastha Ahanatha Pillai1, Vimalraj Velayutham, Senthilkumar Perumal
1Institute of Surgical Gastroenterology and Liver Transplantation, Government Stanley Medical College, Chennai-600001, India.
Biliary cystadenoma, a rare liver neoplasm, requires differentiation from other cysts. Complete resection, such as hepatic resection or cyst enucleation, is the recommended treatment, with no recurrence observed in this series.
Area of Science:
- Hepatology
- Surgical Oncology
- Gastroenterology
Background:
- Biliary cystadenoma is an exceptionally rare benign liver neoplasm, with fewer than 200 reported cases globally.
- Accurate diagnosis and management are crucial due to potential misdiagnosis with other cystic liver lesions.
Purpose of the Study:
- To highlight the radiological findings of biliary cystadenoma.
- To discuss management challenges and outcomes in a series of patients.
Main Methods:
- Retrospective review of 13 patients who underwent surgery for biliary cystadenoma between March 2006 and October 2011.
- Analysis of patient demographics, symptoms, surgical procedures, and follow-up data.
Main Results:
- The majority of patients were female (11/13) with a median age of 46 years.
- Abdominal pain was the most common symptom (92%).
- Complete resection was achieved in 10 patients, with no recurrence during follow-up periods ranging from 3 months to 5 years.
Conclusions:
- Biliary cystadenoma necessitates differentiation from other benign liver cysts.
- Hepatic resection or cyst enucleation are the preferred treatment modalities for biliary cystadenoma.
More Related Videos
04:14Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
Published on: February 28, 2025
05:22Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
Published on: February 13, 2026